{"id":"placebo-of-ad-2081","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5075693","moleculeType":"Unknown","molecularWeight":"534.62"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological pathways or receptors, and its purpose is to serve as a control in clinical trials.","oneSentence":"This drug is a placebo for AD-2081, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:00.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control for AD-2081"}]},"trialDetails":[{"nctId":"NCT04825561","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of AD-208","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2021-06-09","conditions":"Androgenetic Alopecia","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"placebo of AD-2081","genericName":"placebo of AD-2081","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is a placebo for AD-2081, meaning it has no active therapeutic effect. Used for Placebo control for AD-2081.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}